TargetedOnc articles Copyright (c) 2009 Intellisphere, LLC. All rights reserved. http://www.targetedonc.com/articles TargetedOnc articles TargetedOnc articles en-us Fri, 28 Nov 2014 05:40:48 EST 5 TargetedOnc articles 144 47 http://www.targetedonc.com/articles http://www.targetedonc.com/_media/_core/mainLogo.png <![CDATA[To Combine or Sequence Anti-PD-1 and Anti-PD-L1 in Question]]>http://www.targetedonc.com/publications/special-reports/2014/immunotherapy-issue4/To-Combine-or-Sequence-Anti-PD-1-and-Anti-PD-L1-in-QuestionTargetedOnc articlesusWed, 26 Nov 2014 10:10:18 ESTTargetedOnc<![CDATA[Programs Prepare for Immuno-Oncology in Clinical Setting]]>http://www.targetedonc.com/publications/special-reports/2014/immunotherapy-issue4/Programs-Prepare-for-Immuno-Oncology-in-Clinical-SettingTargetedOnc articlesusTue, 25 Nov 2014 17:15:38 ESTTargetedOnc<![CDATA[Right Patient for Immunotherapy in NSCLC Explored]]>http://www.targetedonc.com/publications/special-reports/2014/immunotherapy-issue4/Right-Patient-for-Immunotherapy-in-NSCLC-ExploredTargetedOnc articlesusTue, 25 Nov 2014 17:15:01 ESTTargetedOnc<![CDATA[Immunotherapies for Prostate Cancer]]>http://www.targetedonc.com/publications/special-reports/2014/immunotherapy-issue4/Immunotherapies-for-Prostate-CancerTargetedOnc articlesusTue, 25 Nov 2014 16:11:19 ESTTargetedOnc<![CDATA[Weight May Affect Toxicity of Immunotherapies]]>http://www.targetedonc.com/publications/special-reports/2014/immunotherapy-issue4/Weight-May-Affect-Toxicity-of-ImmunotherapiesTargetedOnc articlesusTue, 25 Nov 2014 16:00:15 ESTTargetedOnc<![CDATA[Adverse Events Associated With Immunotherapy in Lung Cancer]]>http://www.targetedonc.com/publications/special-reports/2014/immunotherapy-issue4/Adverse-Events-Associated-With-Immunotherapy-in-Lung-CancerTargetedOnc articlesusTue, 25 Nov 2014 15:16:01 ESTTargetedOnc<![CDATA[Immunotherapy Potential Option in Mesothelioma Treatment]]>http://www.targetedonc.com/publications/special-reports/2014/immunotherapy-issue4/Immunotherapy-Potential-Option-in-Mesothelioma-TreatmentTargetedOnc articlesusTue, 25 Nov 2014 15:12:18 ESTTargetedOnc<![CDATA[Potential Immunotherapies for Head and Neck Cancers]]>http://www.targetedonc.com/publications/special-reports/2014/immunotherapy-issue4/Potential-Immunotherapies-for-Head-and-Neck-CancersTargetedOnc articlesusTue, 25 Nov 2014 14:59:26 ESTTargetedOnc<![CDATA[Immune Checkpoint Inhibitors for Renal Cell Carcinoma]]>http://www.targetedonc.com/publications/targeted-therapies-cancer/2014/october-2014/Immune-Checkpoint-Inhibitors-for-Renal-Cell-CarcinomaTargetedOnc articlesusTue, 25 Nov 2014 12:06:34 ESTTargetedOnc<![CDATA[JCAR015 Receives Breakthrough Designation for ALL]]>http://www.targetedonc.com/articles/JCAR015-Receives-Breakthrough-Designation-for-ALLTargetedOnc articlesusMon, 24 Nov 2014 17:25:16 ESTTargetedOnc a Targeted Oncology